Parker Institute for Cancer Immunotherapy
San Francisco, CA USA

Our News on Newswise

Newswise: Microbiome_WHATSNEW_body.jpg

Probiotics Linked to Poorer Response to Cancer Immunotherapy in Skin Cancer Patients

Taking over-the-counter probiotic supplements was associated with a 70 percent lower chance of response to cancer immunotherapy treatment with anti-PD-1 checkpoint inhibitors in melanoma patients, according to a preliminary study from the Parker...
26-Mar-2019 12:00 PM EDT Add to Favorites

Newswise: Prince_WHATSNEW_body.png

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

Combining immunotherapy with chemotherapy shrank tumors in 20 out of 24 patients with advanced pancreatic cancer, according to early phase 1b data being unveiled at AACR 2019 by Parker Institute for Cancer Immunotherapy (PICI) researchers at the...
26-Mar-2019 9:00 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort.

The Parker Institute is an unprecedented collaboration between the country’s leading immunologists and cancer centers. The program started by providing institutional support to six academic centers, including Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center. The institute also provides programmatic support for top immunotherapy investigators, including a group of researchers at Dana-Farber Cancer Institute, Robert Schreiber, Ph.D., of Washington University School of Medicine in St. Louis, Nina Bhardwaj, M.D., Ph.D., of the Icahn School of Medicine at Mount Sinai, Philip Greenberg, M.D., of the Fred Hutchinson Cancer Research Center, Stephen Forman, M.D., of City of Hope, and James Heath, Ph.D., of the Institute for Systems Biology.

The Parker Institute network also includes more than 40 industry and nonprofit partners, more than 60 labs and more than 170 of the nation’s top researchers focused on treating the deadliest cancers. The goal is to accelerate the development of breakthrough immune therapies capable of turning most cancers into curable diseases. The institute was created through a $250 million grant from The Parker Foundation.


Jennifer Haslip
Vice President of Communications

(415) 930-4346

Anna Prince
Senior Director, Marketing and Communications


Jennifer Yim
Marketing and Communications Coordinator